Afya Limited

Afya Limited(AFYA)の株式分析

$10.640

-3.138 (-29.49%)終値時点

Loading chart…
高値
12.540
始値
11.710
出来高加重平均価格
11.08
出来高
1.77M
時価総額
1.53B
安値
10.050
売買代金
19.59M
EV/EBITDA(TTM)
2.04

Afya Ltd is a Brazil-based company engaged in the education sector. The Company is mainly focused on operating medical schools, offering health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine. In addition, the Firm provides degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. The Company's methodological approach combines integrated content, interactive learning, and an adaptive experience for learners. Through its educational content and technology-enabled activities, the Company focuses on personalized learning that mirrors one-on-one tutoring. The Company's undergraduate and graduate campuses are spread across Brazil, as well as its digital medical platform.

ir.afya.com.br

AI分析 of Afya Limited (AFYA)

買い

Afya Ltd is a good buy right now due to its strong revenue growth and favorable analyst upgrades. The current price is $15.09, and the forward P/E ratio is 7.86, indicating it is undervalued compared to its earnings potential. Additionally, the RSI is at 72.67, suggesting strong momentum, although it is approaching overbought territory. The main risk is the insider selling, which has increased by 1215.03% over the last month, indicating potential concerns among insiders about the stock's future performance.

バリュエーション指標

Afya Limited(AFYA)の現在の予想PERは7.86で、5年平均は10.88です。

予想PER

割安
5年平均 P/E
10.88
現在のP/E
7.86
割高
13.51
割安
8.25

予想EV/EBITDA

割安
5年平均 EV/EBITDA
6.30
現在のEV/EBITDA
2.04
割高
8.50
割安
4.10

予想PSR

大幅な割安
5年平均 P/S
2.06
現在のP/S
0.31
割高
2.93
割安
1.19

Alphio AI による AFYA の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%AFYA

$28.55

シナリオ価格

基

基本

基本 · 50%AFYA

$24.23

シナリオ価格

弱

弱気

弱気 · 25%AFYA

$20.66

シナリオ価格

AFYA を保有するクジラ

S

SoftBank Group Corp.

+ を保有AFYA

-1.57%

3か月リターン

イベントタイムライン

2026-08-24 (ET)

10:00:00

Afya and Yduqs Discuss Potential Business Combination

2025-11-12 (ET)

18:14:48

Afya announces Q3 adjusted EBITDA of R$398.9M, a 14.6% increase year-over-year

2025-11-07 (ET)

08:54:49

Afya Reveals Expansion of Medical Seats at ITPAC Porto Nacional

ニュース

AFYA のよくある質問 — Alphio AI が回答

Afya Ltd is a Brazil-based company engaged in the education sector. The Company is mainly focused on operating medical schools, offering health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine. In addition, the Firm provides degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. The Company's methodological approach combines integrated content, interactive learning, and an adaptive experience for learners. Through its educational content and technology-enabled activities, the Company focuses on personalized learning that mirrors one-on-one tutoring. The Company's undergraduate and graduate campuses are spread across Brazil, as well as its digital medical platform. It operates in the Academic & Educational Services sector.

Afya Ltd is a good buy right now due to its strong revenue growth and favorable analyst upgrades. The current price is $15.09, and the forward P/E ratio is 7.86, indicating it is undervalued compared to its earnings potential. Additionally, the RSI is at 72.67, suggesting strong momentum, although it is approaching overbought territory. The main risk is the insider selling, which has increased by 1215.03% over the last month, indicating potential concerns among insiders about the stock's future performance.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める